K. Jaakkola et al., Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans, J AM COL C, 36(1), 2000, pp. 122-129
Citations number
31
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
OBJECTIVE The expression of endothelial adhesion molecules and their functi
onal significance in leukocyte adhesion to human myocardial blood vessels i
n acute myocardial infarction (AMI) were studied.
BACKGROUND Leukocyte extravasation, mediated by specific adhesion molecules
, exacerbates tissue injury after restoration of blood supply to an ischemi
c tissue. Experimental myocardial reperfusion injury can be alleviated with
antibodies that block the function of adhesion molecules involved in leuko
cyte emigration, but the relevant molecules remain poorly characterized in
human
METHODS Semiquantitative immunohistochemistry and in vitro adhesion assays
were used to study the expression and granulocyte binding abilities of diff
erent endothelial adhesion molecules in human AMI. Changes in the molecular
nature of vascular adhesion protein-1 (VAP-1) were evaluated using immunob
lotting.
RESULTS Certain endothelial adhesion molecules (intercellular adhesion mole
cule [ICAM-2], CD31 and CD73) were expressed in myocardial blood vessels ho
mogeneously in normal and ischemic hearts, whereas others (E-selectin and p
eripheral lymph node addressin) were completely absent from all specimens.
The synthesis of ICAM-1 was locally, and that of P-selectin regionally, upr
egulated in the infarcted hearts when compared with nonischemic controls. V
ascular adhesion protein-1 showed ventricular preponderance in expression a
nd alterations in posttranslational modifications during ischemia-reperfusi
on. Importantly, P-selectin, ICAM-1 and VAP-1 mediated granulocyte binding
to blood vessels in the ischemic human heart.
CONCLUSION Human P-selectin, ICAM-1 and VAP-1 appear to be the most promisi
ng targets when antiadhesive interventions preventing leukocyte-mediated ti
ssue destruction after myocardial ischemia are planned. (J Am Cell Cardiol
2000;36:122-9) (C) 2000 by the American College of Cardiology.